Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Bio-Techne is a US provider of products for research and diagnostics. The company supplies proteins, antibodies and reagents for labs as well as analytical instruments and diagnostic tests. Customers are universities, pharmaceutical companies and hospitals worldwide. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Biotechnology and vaccines · Minneapolis, USAfull fact sheet
The company develops, manufactures and sells reagents, instruments and services for research, diagnostics and bioprocessing worldwide. The Protein Sciences segment supplies biological reagents such as cytokines, antibodies and small molecules as well as protein analysis instruments, for example under the R&D Systems, Tocris Biosciences and ProteinSimple brands. Customers of this segment include researchers in academia and industry, there mainly in pharmaceutical and biotech companies; sales run directly, through a distribution agreement with Thermo Fisher Scientific and through other distributors. The Diagnostics and Spatial Biology segment offers in situ hybridization (ISH) assays under the ACD brand as well as diagnostic products under the Asuragen brand. Diagnostic controls and calibrators go mainly to instrument makers as OEM supplies.
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Fundamentals · Analysis method
Growth, margin, balance sheet, cash flow and dividend compared with the sector – with traffic lights and quality checks in the fundamental analysis. To the fundamental analysis ↓
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Bio-Techne · Sector Health Care · amounts in USD
Source: SEC filings, As of Aug 24, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 5.2x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
✓met: Profit in each of the last 5 fiscal years5 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✓met: Equity ratio above 30%81.5%
Gross margin
65.8%Fiscal year 2026
All76strong
Rank 76 of 100: higher than 76% of 370 peers (All). strong.
Sector58medium
Rank 58 of 100: higher than 58% of 49 peers (Sector). medium.
Median Health Care: 61.8%
Share of revenue left after the direct cost of the products sold.
Operating margin
20.7%Fiscal year 2026
All66medium
Rank 66 of 100: higher than 66% of 470 peers (All). medium.
Sector71strong
Rank 71 of 100: higher than 71% of 54 peers (Sector). strong.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
15.0%Fiscal year 2026
All62medium
Rank 62 of 100: higher than 62% of 584 peers (All). medium.
Sector63medium
Rank 63 of 100: higher than 63% of 63 peers (Sector). medium.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on equity
8.6%Fiscal year 2026
All32weak
Rank 32 of 100: higher than 32% of 544 peers (All). weak.
Sector27weak
Rank 27 of 100: higher than 27% of 54 peers (Sector). weak.
Median Health Care: 12.8%
Net income divided by equity at fiscal year end.
Return on assets
7.0%Fiscal year 2026 (total assets at year end)
All63medium
Rank 63 of 100: higher than 63% of 594 peers (All). medium.
Sector55medium
Rank 55 of 100: higher than 55% of 63 peers (Sector). medium.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
81.5%Fiscal year 2026
All96strong
Rank 96 of 100: higher than 96% of 595 peers (All). strong.
Sector98strong
Rank 98 of 100: higher than 98% of 63 peers (Sector). strong.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
21.7%Fiscal year 2026
All80strong
Rank 80 of 100: higher than 80% of 465 peers (All). strong.
Sector78strong
Rank 78 of 100: higher than 78% of 61 peers (Sector). strong.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
263.2M USDFiscal year 2026
Operating cash flow minus capital expenditure on property and equipment.
Growth 4 of 7 met
✗not met: Over 3 years, revenue grew by more than 5% per year+2.2%
✓met: Over 5 years, revenue grew by more than 5% per year+5.5%
✓met: Over 10 years, revenue grew by more than 5% per year+9.3%
✗not met: Over 3 years, EPS grew by more than 5% per year−13.0%
✓met: Over 5 years, EPS grew by more than 5% per year+6.0%
✓met: Revenue rose in at least 4 of the last 5 fiscal years4 of 5
✗not met: Revenue rose in the last fiscal year−0.4%
Revenue growth 3 years
+2.2%per year
All31weak
Rank 31 of 100: higher than 31% of 578 peers (All). weak.
Sector36medium
Rank 36 of 100: higher than 36% of 62 peers (Sector). medium.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+5.5%per year
All30weak
Rank 30 of 100: higher than 30% of 549 peers (All). weak.
Sector29weak
Rank 29 of 100: higher than 29% of 60 peers (Sector). weak.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+9.3%per year
All67strong
Rank 67 of 100: higher than 67% of 412 peers (All). strong.
Sector51medium
Rank 51 of 100: higher than 51% of 50 peers (Sector). medium.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
−13.0%per year
All16weak
Rank 16 of 100: higher than 16% of 437 peers (All). weak.
Sector16weak
Rank 16 of 100: higher than 16% of 54 peers (Sector). weak.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
+6.0%per year
All31weak
Rank 31 of 100: higher than 31% of 399 peers (All). weak.
Sector37medium
Rank 37 of 100: higher than 37% of 47 peers (Sector). medium.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
+5.2%per year
All28weak
Rank 28 of 100: higher than 28% of 375 peers (All). weak.
Sector27weak
Rank 27 of 100: higher than 27% of 46 peers (Sector). weak.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 6 of 7 met
✓met: Pays a dividend0.32 USD
✓met: Payout ratio at most 60% of earnings28%
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✓met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.never
✗not met: Dividend per share higher than 5 years ago0.0%
✓met: Free cash flow per share covers the dividend5.2x
✓met: Dividends paid over the last 5 years covered by free cash flow20% of free cash flow
Payout ratio
28%Fiscal year 2026
Dividend per share divided by earnings per share.
Dividend growth 5 years
0.0%per year
All6weak
Rank 6 of 100: higher than 6% of 321 peers (All). weak.
Sector8weak
Rank 8 of 100: higher than 8% of 31 peers (Sector). weak.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
5.2xFiscal year 2026
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 6 of 6 met
✓met: Piotroski F-Score at least 7 of 99 of 9
✓met: Long-term debt no higher than equity0.09
✓met: Current assets cover current liabilities4.55
✓met: Positive equity2.1B USD
✓met: In 5 years, share count up by at most 5%−3.0%
✓met: Free cash flow positive in the last fiscal year263.2M USD
Piotroski F-Score
9 of 9Fiscal year 2026
All98strong
Rank 98 of 100: higher than 98% of 310 peers (All). strong.
Sector96strong
Rank 96 of 100: higher than 96% of 47 peers (Sector). strong.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
0.09at fiscal year end
All90strong
Rank 90 of 100: lower than 90% of 486 peers (All). strong.
Sector87strong
Rank 87 of 100: lower than 87% of 50 peers (Sector). strong.
Median Health Care: 0.66
Long-term financial debt divided by equity.
Liquidity (current ratio)
4.55at fiscal year end
All93strong
Rank 93 of 100: higher than 93% of 513 peers (All). strong.
Sector94strong
Rank 94 of 100: higher than 94% of 63 peers (Sector). strong.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−3.0%in 5 years
All51medium
Rank 51 of 100: lower than 51% of 507 peers (All). medium.
Sector43medium
Rank 43 of 100: lower than 43% of 59 peers (Sector). medium.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✓met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✓met: Liquidity (current assets / current liabilities) rose
✓met: No additional shares (diluted share count did not rise)
✓met: Gross margin higher than the prior year
✓met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light yellow: Revenue grew over 5 years (+5.5% per year), more slowly than the sector median.
Light yellow: Net income (total) grew over 5 years (+5.3% per year), more slowly than the sector median; per share +6.0% per year.
Light green: Net margin 15.0%, above the sector median (13.9%).
Light green: Debt not higher than usual in the sector.
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
0500M1B1.5B
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Revenue 563.0M USD · Net income 76.1M USD · Net margin 13.5%
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Revenue 643.0M USD · Net income 126.2M USD · Net margin 19.6%
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Revenue 714.0M USD · Net income 96.1M USD · Net margin 13.5%
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Revenue 738.7M USD · Net income 229.3M USD · Net margin 31.0%
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Revenue 931.0M USD · Net income 140.4M USD · Net margin 15.1%
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Revenue 1.1B USD · Net income 272.1M USD · Net margin 24.6%
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Revenue 1.1B USD · Net income 285.3M USD · Net margin 25.1%
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Revenue 1.2B USD · Net income 168.1M USD · Net margin 14.5%
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Revenue 1.2B USD · Net income 73.4M USD · Net margin 6.0%
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 1.2B USD · Net income 181.9M USD · Net margin 15.0%
Margin
14%20%13%31%15%25%25%15%6.0%15%
RevenueNet incomeNet margin (below)in USD
0100M200M300M400M
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 272.6M USD · Net income 27.5M USD · Net margin 10.1%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 303.4M USD · Net income 49.1M USD · Net margin 16.2%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue not available · Net income 40.6M USD · Net margin not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 289.5M USD · Net income 33.6M USD · Net margin 11.6%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 297.0M USD · Net income 34.9M USD · Net margin 11.7%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 316.2M USD · Net income 22.6M USD · Net margin 7.1%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 317.0M USD · Net income −17.7M USD · Net margin −5.6% · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 286.6M USD · Net income 38.2M USD · Net margin 13.3%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 295.9M USD · Net income 38.0M USD · Net margin 12.8%
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 311.4M USD · Net income 51.0M USD · Net margin 16.4%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 321.2M USD · Net income not available · Net margin not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 299.7M USD · Net income 28.3M USD · Net margin 9.4%
Margin
10%16%12%12%7.1%−5.6%13%13%16%9.4%
Earnings per shareUSD per share
00.501.001.502.00
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Earnings per share 0.51 USD (adjusted for split 4:1)
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Earnings per share 0.83 USD (adjusted for split 4:1)
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Earnings per share 0.62 USD (adjusted for split 4:1)
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Earnings per share 1.46 USD (adjusted for split 4:1)
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Earnings per share 0.87 USD (adjusted for split 4:1)
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Earnings per share 1.66 USD (adjusted for split 4:1)
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Earnings per share 1.76 USD
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Earnings per share 1.05 USD
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Earnings per share 0.46 USD
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Earnings per share 1.16 USD
Earnings per shareUSD per share
00.100.200.300.40
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share 0.17 USD
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 0.31 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share not reported separately for Q4
Dividend per sharePayout ratio (below)USD per share
00.100.200.300.40
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Dividend per share 0.32 USD · Payout ratio 63.1%
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Dividend per share 0.32 USD · Payout ratio 38.7%
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Dividend per share 0.32 USD · Payout ratio 51.8%
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Dividend per share 0.32 USD · Payout ratio 22.0%
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Dividend per share 0.32 USD · Payout ratio 36.9%
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Dividend per share 0.32 USD · Payout ratio 19.3%
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Dividend per share 0.32 USD · Payout ratio 18.2%
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Dividend per share 0.32 USD · Payout ratio 30.5%
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Dividend per share 0.32 USD · Payout ratio 69.6%
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Dividend per share 0.32 USD · Payout ratio 27.6%
Ratio
63%39%52%22%37%19%18%30%70%28%
Dividend per sharePayout ratio (below)USD per share
00.100.200.30
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 0.08 USD · Payout ratio 47.1%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 0.08 USD · Payout ratio 25.8%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 0.24 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 0.08 USD · Payout ratio 38.1%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 0.08 USD · Payout ratio 36.4%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 0.08 USD · Payout ratio 57.1%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 0.08 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 0.08 USD · Payout ratio 33.3%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 0.08 USD · Payout ratio 33.3%
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 0.08 USD · Payout ratio 25.0%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 0.08 USD · Payout ratio 44.4%
Ratio
47%26%38%36%57%33%33%25%44%
Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 1.2B USD · Net income 181.9M USD · Net margin 15.0%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +4.6% vs. the same quarter a year earlier; grown for 2 quarters in a row.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
25.1%
Fiscal year 2026: 21.7%
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Jun 30, 2026 1.2B USD + year to date to Sep 30, 2026 299.7M USD − same period a year earlier to Sep 30, 2025 286.6M USD = 1.2B USD
Net income: fiscal year to Jun 30, 2026 181.9M USD + year to date to Sep 30, 2026 28.3M USD − same period a year earlier to Sep 30, 2025 38.2M USD = 172.0M USD
Operating cash flow: fiscal year to Jun 30, 2026 292.1M USD + year to date to Sep 30, 2026 73.1M USD − same period a year earlier to Sep 30, 2025 27.6M USD = 337.6M USD
Capital expenditure: fiscal year to Jun 30, 2026 28.9M USD + year to date to Sep 30, 2026 5.9M USD − same period a year earlier to Sep 30, 2025 5.4M USD = 29.4M USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
299.7M
+4.6%
28.3M
9.4%
Apr–Jun 26*
321.2M
+1.3%
–
–
Jan–Mar 26
311.4M
−1.5%
51.0M
16.4%
Oct–Dec 25
295.9M
−0.4%
38.0M
12.8%
Jul–Sep 25
286.6M
−1.0%
38.2M
13.3%
Apr–Jun 25*
317.0M
–
−17.7M
−5.6%
Jan–Mar 25
316.2M
–
22.6M
7.1%
Oct–Dec 24
297.0M
–
34.9M
11.7%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
As of: 12 months to Sep 30, 2026, filed on Nov 6, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is backed by cash; interest is well covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
1.61x
0.81.0
backed from 1.0 · 3 years: 2.08x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
26.2x
25
well covered from 5 · 3 years: 16.6x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
24.4%
for information only · 3 years: 19.3%
More depth
Calculation for fiscal year 2026
Operating cash flow 292.1M USD ÷ Net income 181.9M USD = 1.61x
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2026 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years no loss year and one year with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
0 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
1 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
25.0 percentage points
from 6.0% to 31.0%
▾20172026Net margin by fiscal year · ▾ revenue below the prior yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2026
−0.4%
15.0%
2025
+5.2%
6.0%
2024
+2.0%
14.5%
2023
+2.8%
25.1%
2022
+18.7%
24.6%
2021
+26.0%
15.1%
2020
+3.5%
31.0%
2019
+11.0%
13.5%
2018
+14.2%
19.6%
2017
+12.8%
13.5%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2017–2026 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2026
Of 100 USD of revenue, 65.8 USD gross profit, 20.7 USD operating income and 15.0 USD net income remained.
2017Fiscal year 2017: Operating cash flow 143.7M USD · Capital expenditure 15.2M USD · Free cash flow 128.5M USD
2018Fiscal year 2018: Operating cash flow 170.4M USD · Capital expenditure 20.9M USD · Free cash flow 149.4M USD
2019Fiscal year 2019: Operating cash flow 181.6M USD · Capital expenditure 25.4M USD · Free cash flow 156.2M USD
2020Fiscal year 2020: Operating cash flow 205.2M USD · Capital expenditure 51.7M USD · Free cash flow 153.5M USD
2021Fiscal year 2021: Operating cash flow 352.2M USD · Capital expenditure 44.3M USD · Free cash flow 307.9M USD
2022Fiscal year 2022: Operating cash flow 325.3M USD · Capital expenditure 44.9M USD · Free cash flow 280.4M USD
2023Fiscal year 2023: Operating cash flow 254.4M USD · Capital expenditure 38.2M USD · Free cash flow 216.1M USD
2024Fiscal year 2024: Operating cash flow 299.0M USD · Capital expenditure 62.9M USD · Free cash flow 236.1M USD
2025Fiscal year 2025: Operating cash flow 287.6M USD · Capital expenditure 31.0M USD · Free cash flow 256.6M USD
2026Fiscal year 2026: Operating cash flow 292.1M USD · Capital expenditure 28.9M USD · Free cash flow 263.2M USD
Share count
The share count fell in 5 years by 3.0% (mostly through share repurchases).
Diluted share count
050M100M150M200M
2017Fiscal year 2017: Diluted share count 150.0M
2018Fiscal year 2018: Diluted share count 152.2M
2019Fiscal year 2019: Diluted share count 155.6M
2020Fiscal year 2020: Diluted share count 157.6M
2021Fiscal year 2021: Diluted share count 161.9M
2022Fiscal year 2022: Diluted share count 164.1M
2023Fiscal year 2023: Diluted share count 161.9M
2024Fiscal year 2024: Diluted share count 160.8M
2025Fiscal year 2025: Diluted share count 159.7M
2026Fiscal year 2026: Diluted share count 157.0M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Earnings per share
Earnings per share rose in 5 years from 0.87 USD to 1.16 USD.
TECHUSD per share
00.501.001.502.00
2017Fiscal year 2017: TECH 0.51 USD
2018Fiscal year 2018: TECH 0.83 USD
2019Fiscal year 2019: TECH 0.62 USD
2020Fiscal year 2020: TECH 1.46 USD
2021Fiscal year 2021: TECH 0.87 USD
2022Fiscal year 2022: TECH 1.66 USD
2023Fiscal year 2023: TECH 1.76 USD
2024Fiscal year 2024: TECH 1.05 USD
2025Fiscal year 2025: TECH 0.46 USD
2026Fiscal year 2026: TECH 1.16 USD
Revenue
Revenue rose in 5 years from 931.0M USD to 1.2B USD.
TECHin USD
0500M1B1.5B
2017Fiscal year 2017: TECH 563.0M USD
2018Fiscal year 2018: TECH 643.0M USD
2019Fiscal year 2019: TECH 714.0M USD
2020Fiscal year 2020: TECH 738.7M USD
2021Fiscal year 2021: TECH 931.0M USD
2022Fiscal year 2022: TECH 1.1B USD
2023Fiscal year 2023: TECH 1.1B USD
2024Fiscal year 2024: TECH 1.2B USD
2025Fiscal year 2025: TECH 1.2B USD
2026Fiscal year 2026: TECH 1.2B USD
Net margin
The net margin stayed roughly the same in 5 years (15.0%).
TECHSector today 14.6%Mark in the latest year: today’s median of the Health Care sector as in the sector comparison (each latest fiscal year). We do not have earlier medians.
0%10%20%30%40%
2017Fiscal year 2017: TECH 13.5%
2018Fiscal year 2018: TECH 19.6%
2019Fiscal year 2019: TECH 13.5%
2020Fiscal year 2020: TECH 31.0%
2021Fiscal year 2021: TECH 15.1%
2022Fiscal year 2022: TECH 24.6%
2023Fiscal year 2023: TECH 25.1%
2024Fiscal year 2024: TECH 14.5%
2025Fiscal year 2025: TECH 6.0%
2026Fiscal year 2026: TECH 15.0% · Sector today 14.6%
Source: SEC filings, fiscal years up to Jun 30, 2026. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 5.2x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
at least 10
as far as the data goes
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
0.0%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
5.2x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2021 0.32 USD → fiscal year 2026 0.32 USD = 0.0% per year
Free cash flow per share 1.68 USD ÷ dividend per share 0.32 USD = 5.2x
Years without a cut: in a row up to fiscal year 2026, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is about at its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
0.32USD · Fiscal year 2026
Dividend growth per year
3 y0.0%5 y0.0%10 y0.0%
Payout ratio
of earnings28%of free cash flow19%
To shareholders (5 years)
829.2M USD70% through repurchases
Share count over 5 years
−3.0%fewer shares – each share is a larger stake
Dividend per share
The dividend per share stayed roughly the same in 5 years (0.32 USD).
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
00.100.200.300.40
2017Fiscal year 2017: Dividend per share 0.32 USD
2018Fiscal year 2018: Dividend per share 0.32 USD
2019Fiscal year 2019: Dividend per share 0.32 USD
2020Fiscal year 2020: Dividend per share 0.32 USD
2021Fiscal year 2021: Dividend per share 0.32 USD
2022Fiscal year 2022: Dividend per share 0.32 USD
2023Fiscal year 2023: Dividend per share 0.32 USD
2024Fiscal year 2024: Dividend per share 0.32 USD
2025Fiscal year 2025: Dividend per share 0.32 USD
2026Fiscal year 2026: Dividend per share 0.32 USD
Payout ratios
The payout ratio fell in 5 years from 36.9% to 27.6%.
Payout ratio (earnings)Payout ratio (free cash flow)
0%20%40%60%80%
2017Fiscal year 2017: Payout ratio (earnings) 63.1% · Payout ratio (free cash flow) 36.8%
2018Fiscal year 2018: Payout ratio (earnings) 38.7% · Payout ratio (free cash flow) 32.1%
2019Fiscal year 2019: Payout ratio (earnings) 51.8% · Payout ratio (free cash flow) 31.0%
2020Fiscal year 2020: Payout ratio (earnings) 22.0% · Payout ratio (free cash flow) 31.9%
2021Fiscal year 2021: Payout ratio (earnings) 36.9% · Payout ratio (free cash flow) 16.1%
2022Fiscal year 2022: Payout ratio (earnings) 19.3% · Payout ratio (free cash flow) 17.9%
2023Fiscal year 2023: Payout ratio (earnings) 18.2% · Payout ratio (free cash flow) 23.3%
2024Fiscal year 2024: Payout ratio (earnings) 30.5% · Payout ratio (free cash flow) 21.4%
2025Fiscal year 2025: Payout ratio (earnings) 69.6% · Payout ratio (free cash flow) 19.6%
2026Fiscal year 2026: Payout ratio (earnings) 27.6% · Payout ratio (free cash flow) 19.0%
What goes back to shareholders
Over 5 years, 829.2M USD went back to shareholders, 70% of it through share repurchases. That is 66% of the free cash flow of those years.
2017Fiscal year 2017: Dividends paid 47.3M USD · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow 128.5M USD
2018Fiscal year 2018: Dividends paid 48.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 149.4M USD
2019Fiscal year 2019: Dividends paid 48.4M USD · Share repurchases 15.4M USD · New shares issued (including employee plans) not available · Free cash flow 156.2M USD
2020Fiscal year 2020: Dividends paid 48.9M USD · Share repurchases 50.1M USD · New shares issued (including employee plans) not available · Free cash flow 153.5M USD
2021Fiscal year 2021: Dividends paid 49.6M USD · Share repurchases 43.2M USD · New shares issued (including employee plans) not available · Free cash flow 307.9M USD
2022Fiscal year 2022: Dividends paid 50.2M USD · Share repurchases 161.0M USD · New shares issued (including employee plans) not available · Free cash flow 280.4M USD
2023Fiscal year 2023: Dividends paid 50.3M USD · Share repurchases 19.6M USD · New shares issued (including employee plans) not available · Free cash flow 216.1M USD
2024Fiscal year 2024: Dividends paid 50.4M USD · Share repurchases 80.0M USD · New shares issued (including employee plans) not available · Free cash flow 236.1M USD
2025Fiscal year 2025: Dividends paid 50.4M USD · Share repurchases 275.7M USD · New shares issued (including employee plans) not available · Free cash flow 256.6M USD
2026Fiscal year 2026: Dividends paid 49.9M USD · Share repurchases 41.7M USD · New shares issued (including employee plans) not available · Free cash flow 263.2M USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Bio-Techne next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison TECH, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+5.5%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 5.5% per year on average, but more slowly than the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+5.3%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: +6.0% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 5.3% per year on average, but more slowly than the median company in the sector (+5.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 14.97 USD remained as profit – at least as much as the median company in the sector (13.9%). Five years ago the margin was 15.1%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light green: lower than sector
0.09latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 0.09 USD of financial debt – no more than the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light green: covered
28%Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? Of every 1 USD of earnings per share, 0.28 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 56%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
1.2B USD
Revenue vs. prior year
−0.4%
Net income (FY)
181.9M USD
Net income vs. prior year
+147.8%
EPS (FY)
1.16 USD
Superinvestors holding
3 of 26
Fiscal year to Jun 30, 2026 · 10-K filed Aug 24, 2026 · Balance sheet Jun 30, 2026 (filed Aug 24, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2026
Jun 30, 2026
1.2B
181.9M
15.0%
1.16
0.32
28%
2025
Jun 30, 2025
1.2B
73.4M
6.0%
0.46
0.32
70%
2024
Jun 30, 2024
1.2B
168.1M
14.5%
1.05
0.32
30%
2023
Jun 30, 2023
1.1B
285.3M
25.1%
1.76
0.32
18%
2022
Jun 30, 2022
1.1B
272.1M
24.6%
1.66
0.32
19%
2021
Jun 30, 2021
931.0M
140.4M
15.1%
0.87
0.32
37%
2020
Jun 30, 2020
738.7M
229.3M
31.0%
1.46
0.32
22%
2019
Jun 30, 2019
714.0M
96.1M
13.5%
0.62
0.32
52%
2018
Jun 30, 2018
643.0M
126.2M
19.6%
0.83
0.32
39%
2017
Jun 30, 2017
563.0M
76.1M
13.5%
0.51
0.32
63%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
299.7M
28.3M
9.4%
0.18
0.08
44%
Q2/26*
Jun 30, 2026
321.2M
–
–
–
–
–
Q1/26
Mar 31, 2026
311.4M
51.0M
16.4%
0.32
0.08
25%
Q4/25
Dec 31, 2025
295.9M
38.0M
12.8%
0.24
0.08
33%
Q3/25
Sep 30, 2025
286.6M
38.2M
13.3%
0.24
0.08
33%
Q2/25*
Jun 30, 2025
317.0M
−17.7M
−5.6%
–
0.08
–
Q1/25
Mar 31, 2025
316.2M
22.6M
7.1%
0.14
0.08
57%
Q4/24
Dec 31, 2024
297.0M
34.9M
11.7%
0.22
0.08
36%
Q3/24
Sep 30, 2024
289.5M
33.6M
11.6%
0.21
0.08
38%
Q2/24*
Jun 30, 2024
–
40.6M
–
–
0.24
–
Q1/24
Mar 31, 2024
303.4M
49.1M
16.2%
0.31
0.08
26%
Q4/23
Dec 31, 2023
272.6M
27.5M
10.1%
0.17
0.08
47%
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Per-share values adjusted for stock split Stock splitA company divides each share into several new ones; the value of the company stays the same. We convert per-share values from before the split to today’s scale.Example: Split 4 : 1, earnings per share before $11.89 → comparable today $2.97.More in the Academy: Lesson revenue, profit and margin 4:1 (between Nov 7, 2022 and Feb 7, 2023). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Bio-Techne?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Sold out in the latest quarter: Soros Fund Management, Bridgewater Associates.
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score –
We do not calculate a trend score for symbols in the extended universe.
Volatility and trend strength
ADX 14 (trend strength)–
Price change 60 days–
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.